Characterization of vascular endothelial progenitor cells from chicken bone marrow by Chunyu Bai et al.
Bai et al. BMC Veterinary Research 2012, 8:54
http://www.biomedcentral.com/1746-6148/8/54RESEARCH ARTICLE Open AccessCharacterization of vascular endothelial
progenitor cells from chicken bone marrow
Chunyu Bai1,3†, Lingling Hou2†, Minghai Zhang3, Yabin Pu1, Weijun Guan1* and Yuehui Ma1*Abstract
Background: Endothelial progenitor cells (EPC) are a type of stem cell used in the treatment of atherosclerosis,
vascular injury and regeneration. At present, most of the EPCs studied are from human and mouse, whereas the
study of poultry-derived EPCs has rarely been reported. In the present study, chicken bone marrow-derived EPCs
were isolated and studied at the cellular level using immunofluorescence and RT-PCR.
Results: We found that the majority of chicken EPCs were spindle shaped. The growth-curves of chicken EPCs at
passages (P) 1, -5 and -9 were typically “S”-shaped. The viability of chicken EPCs, before and after cryopreservation
was 92.2% and 81.1%, respectively. Thus, cryopreservation had no obvious effects on the viability of chicken EPCs.
Dil-ac-LDL and FITC-UAE-1 uptake assays and immunofluorescent detection of the cell surface markers CD34,
CD133, VEGFR-2 confirmed that the cells obtained in vitro were EPCs. Observation of endothelial-specific
Weibel-Palade bodies using transmission electron microscopy further confirmed that the cells were of endothelial
lineage. In addition, chicken EPCs differentiated into endothelial cells and smooth muscle cells upon induction with
VEGF and PDGF-BB, respectively, suggesting that the chicken EPCs retained multipotency in vitro.
Conclusions: These results suggest that chicken EPCs not only have strong self-renewal capacity, but also the
potential to differentiate into endothelial and smooth muscle cells. This research provides theoretical basis and
experimental evidence for potential therapeutic application of endothelial progenitor cells in the treatment of
atherosclerosis, vascular injury and diabetic complications.
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Endothelial progenitor cells (EPCs) are precursors of
vascular endothelial cells. Progenitor cells [1]. EPCs ori-
ginate from bone marrow with similar angioblast and
umbilical vein endothelial cells, which together belong
to a subgroup of hematopoietic stem cells [2].
There are two types of EPCs that can be detected
in vitro, early and late EPCs. While early EPCs display a
linear growth structure termed spindle-shaped, late
EPCs form cobblestone-like, oval shaped strutures [3].
EPCs not only take part in vascularization during embry-
onic development, but also participate in postnatal
vascularization and reparative processes post-trauma [4].
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reproduction in any medium, provided the ortissue engineering and possible clinical application in
coronary artery disease and wound healing [5]. However,
the therapeutic use of EPCs remains controversial with
many scholars believing that transplantations are reck-
less. In contrast, there have been cases where clinical
transplantation of EPCs for ischemic disease has been
successful [6,7]. Therefore, the therapeutic application of
EPCs has become more and more attractive.
In addition, there is a close link between diabetic com-
plications and decreased number and activity level of
EPCs in vessels [8]. It is hypothesized that the loss of func-
tion and reduced number of EPCs leads to cardiovascular
complications including induced atherosclerosis, heart dis-
ease or apoplexy, which are primary causes of death in
diabetic patients [9]. The initial loss of EPC function is
believed to relate to increased patient weight [10]. In con-
trast, the diabetes-related retinopathy is caused by high
levels of EPCs in the endocapillaries which promote
neurotrophic factor [11]. Thus, EPCs play a key role inThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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esis-associated cancer diffusion [12]. The number of EPCs
in circulation is raised after chemotherapy as revealed by
Roodhart et al, therefore EPCs could be a novel target for
anti-cancer therapy [13]. In summary, EPCs hold great
prospects for future medical application, however, more
in-depth studies are required to investigate the feasibility
of using EPCs in the treatment of the aforementioned dis-
eases. To date, the vast majority of experimental EPCs
have been obtained from humans, mouse and other mam-
mals, but rarely from avian species. As a different model
species, the chicken has an abundance of EPCs. Thus, in
the present study, chicken EPCs were evaluated. EPCs
were isolated from the bone marrow of one day old chick-
ens and cultured in vitro. Cultured cells were verified to
be EPCs by testing for stemness hallmarks: self-renewal
capacity and differentiation abilities; and confirming the
expression of EPC specific surface markers. This research
provides novel insights for the isolation and in vitro cul-
ture of chicken EPCs, and their possible use for tissue re-
construction in avian species.
Materials and methods
Experimental animal
The Institutional Animal Care and Use Committee of
Chinese Academy of Agricultural Sciences approved all
animal procedure.
Sixty one-day-old Beijing Fatty chickens (Gallus gallus)
were provided by the Poultry Experimental Base Institute
of Animal Sciences, Chinese Academy of Agricultural
Sciences, Beijing. All chickens were treated in accordance
with NIH and USDA guidelines for the use of animals in
research and all experimental procedures involving
chickens were conducted in accordance with the proto-
cols and guidelines for agricultural animal research codi-
fied by the Committee for Ethics of Beijing, China.
Experimental reagents
DMEM/F12 (Gibco, USA), special grade fetal bovine
serum (Biochrom,Germany) Percoll lymphocyte separat-
ing (Pharmasha), Trypsin 1: 250 (Amresco), VEGF, bFGF,
IGF-1, PDGF-BB (Invitrogen, USA), rabbit anti chicken
CD34, VEGFR-2 polyclonal antibody (MBL, Japan),
mouse anti CD133 polyclonal antibody, EDTA, FITC
conjugated goat anti mouse secondary antibody IgG,
FITC conjugated goat anti rabbit secondary antibody
IgG (Zhongshan Golden Bridge, China), mouse antiα-
MSA polyclonal antibody (BOSTER),FITC-UEA-1
(Sigma, USA), Dil-ac-LDL(Invitrogen, USA).
Methods
Isolation of chicken EPCs
Thighs obtained from sacrificed experimental chickens
were soaked in 75% alcohol for 3 min. Next, musclesand connective tissues were removed under sterile con-
ditions to obtain the tibias and the metaphyseal was
resected to expose the bone marrow cavity. Using a syr-
inge, bone marrow was removed and resuspended in 10
ml serum-free L-DMEM medium containing 100 IU/ml
penicillin and 100 μg/ml streptomycin. The bone mar-
row cell suspension was then carefully layered over 3 ml
of 1.077 g/ml Percoll solution in a 10 ml centrifuge tube.
The mixture was centrifuged at 400 × g for 20 min at
room temperature and the white nebulous layer was col-
lected, washed twice using L-DMEM and centrifuged for
a further 5 min at 200 × g. After counting, cells were
plated into flasks at 1 × 105 cells/ml, and cultured at 37°
C, 5% CO2. Half of the medium was changed after three
days, and then once every three days thereafter.
The influences of matrix and medium on EPCs culture
The original passage (P0) EPCs were plated at a density
of 1 × 105 cells/well onto 24-well plates coated with ei-
ther 0.1% gelatin or fibronectin, respectively, then cul-
tured in either DMEM/F12 supplemented with 10% FBS,
10ng/ml VEGF, 10ng/ml bFGF and 10ng/ml IGF-1,
dubbed Media A, or M199 supplemented with 10% FBS,
10ng/ml VEGF, 10ng/ml bFGF and 10ng/ml IGF-1,
dubbed Media B. The growth dynamics of EPCs were
then investigated under the different culture conditions
(n = 6/group).
Estimation of cell viability
EPC viability before and after cryopreservation was
detected using the Trypan blue exclusion test as previ-
ously described [14]. The number of non-viable cells
was determined from a total of 104 counted cells.
Growth dynamics
To assess growth dynamics, six individual EPCs of pas-
sages 1, 5, and 9 were seeded in triplicate in 24-well plates
at a density of 1 × 105 cells/well and cultured for seven
days. Cells were counted every day thereafter for up to
eighth days. The mean cell counts at each time point were
used to plot growth curves. Based on this the population
doubling time (PDT) was calculated.as follows: PDT= (t-
t0) lg2/ (lgNt-lgN0), where t0 = starting time of culture; t =
termination time of culture; N0 = initial cell number of
culture; Nt = ultimate cell number of culture.
Dil-ac-LDL and FITC- UEA-l uptake by EPCs
EPCs of passages 1, 5 and 9 were washed thrice (5 min
each) using PBS, then incubated in media containing
12μg/mL Dil-ac-LDL for 4 h at 37°C, 5% CO2. Cells were
then washed thrice more (5 min each), fixed with 2% par-
aformaldehyde, and incubated for 1 h with FITC-UEA-1
(10 μg/ml) at room temperature. Cells were observed
using the Nikon TE-2000-E confocal microscope.
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EPCs of passages 1, 5 and 9 were fixed in 4% (m/v) paraf-
ormaldehyde for 15 min then washed thrice with PBS (5
min each). Cells were permeabilized using 0.2% (v/v) Tri-
ton X-100 for 20 min and washed a further three times (5
min each) with PBS. The cells were blocked in 10% (v/v)
goat serum for 30 min, and subsequently incubated in 3%
(w/v) bovine serum albumin (BSA) containing the follow-
ing antibodies: (1) Mouse α Chicken CD133 (1:100); (2)
Rabbit α Chicken CD34 (1:500); and (3) Rabbit α Chicken
KDR (1:500) for 1 h at room temperature. Next, cells were
washed thrice (10 min each) with PBS, and incubated in
PBS containing the appropriate fluorescein isothiocyanate
(FITC)-conjugated secondary antibody for 1 hr at 37°C.
After incubation, cells were washed thrice with PBS (10
min each). The cells were observed using the Nikon TE-
2000-E confocal microscope. Ten non-overlapping visual
fields were randomly selected. Images were acquired and
used to calculate positive ratios.
Detection of weibel-palade bodies
Weible-Palade bodies were observed by transmission
electron microscopy after fixation, dehydration,
permeabilization and sectioning of EPCs collected at
passages 1, -5 and -9.
Endothelial differentiation
EPCs were divided into two groups: induced and control.
When EPCs attained 60%–70% confluence, cells of the
induced group were incubated with endotheliocyte media
containing 30ng/ml VEGF, while control cells remained in
complete medium alone. Media were refreshed every
three days and three weeks later mRNA expression of
CD31, CD34 and CD133 was assessed via RT-PCR. Non-
induced EPCs were used as a negative control.
Smooth muscle cell differentiation
The cells were divided into two groups, induced and con-
trol. When EPCs attained 60%–70% confluence, cells of
the induced group were incubated in endotheliocyte
media containing 20ng/ml PDGF-BB, while control cells
remained in complete medium alone. The media were








GAPDH F:5′ TAAAGGCGAGATGGTGAAAG 3′
R: 5′ ACGCTCCTGGAAGATAGTGAT 3′expression of α-MSA and CD133 were assessed via RT-
PCR. Non-induced EPCs were used as a negative control.
Reverse transcription PCR (RT-PCR)
Collect the cells, extract total RNA with Trizol (Invitro-
gen). Total RNA was reverse transcribed followed by 30
PCR cycles using RNA PCR kit ver 3.0 (TARAKA,
China). Information of gene specific primer pairs was
listed in Table 1. PCR was performed in a 25μl mixture
containing 2.5μl 10 × PCR Buffer (TARAKA, China), 2μl
dNTP Mix (2.5mM) (TARAKA, China), 16.75μl ddH2O,
0.25μl Ex-Taq (TARAKA, China), 1μl forward and re-
verse primers, and 1.5μl template cDNA. The cycling
conditions consisted of initial 5 min at 94°C 0ne cycle
and than followed by 30 cycles of 30s at 94°C (for de-
naturation), 30s at 50-60°C(for annealing), 2 min at 72°C
( for extension). PCR products were detected by 2.5%
agarose gel electrophoresis.
Statistical analysis
Statistical analyses of the data were performed with a
one-way ANOVA followed by the Tukey-Kramer hon-
estly significant difference (HSD) test for the three sets
of results. A P-value of less than 0.05 was considered
significant. Statistical analyses were done with a JMPW
Statistical Discovery Software (SAS Institute, Cary, NC).
Results
Optimization of in vitro culture condition
To determine the optimal culture conditions for chicken
EPCs, two adhesive compounds were tested: gelatin (0.1%)
and fibronectin. Two types of media, dubbed A and B,
were also evaluated. Passage 0 (P0) EPCs (1 × 105) were
seeded onto culture plates coated with 0.1% gelatin or
fibronectin, and cultured in either media A or media B.
EPC growth was monitored by daily counting to generate
growth curves. The growth curves suggested that combin-
ing media A with 0.1% gelatin coated plates provided the
optimal culture system for EPCs (Figure 1).
EPCs morphological
To further characterize the chicken EPCs, morphological





Figure 1 The growth curves of EPCs under different culture
conditions. The growth curves of EPCs appeared sigmoidal under
the “Media A & Gelatin” culture conditions. Other curves did not
appear sigmoidal. The population doubling times (PDT) were
approximately 31.9 h (Media A & Gelatin), 40.5 h (Media B & Gelatin),
43.6 h (Media A & Fibronectin) and 52.7 h (Media B & Fibronectin).
“Media A & Gelatin” was determined to provide the optimal
conditions for the proliferation of EPCs in vitro.
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shaped (Figure 2A), however within 48 h they adhered
and began growing. The cells proliferated quickly, dis-
playing obvious karyokinesis and differing morphology
including fusiform, triangular and irregular shapes. After
5 days in culture, colonies formed,where rounded cells
were found in the middle of clusters, but peripheral cells
were more fusiform in shape, and radiated from the
centre as single cells. These clusters were termed, “blood
islands” (Figure 2B). Linear arrangements of cellFigure 2 Morphology of chicken EPCs in vitro. A. Cells plated onto mic
slabstone-like appearance of the EPCs; D. linear growth of the EPCs; E. P1 E
passage; H. P7 EPCs before passage; I. P9 EPCs (bar = 100μm).structures were also observed (Figure 2C). Approxi-
mately eight days after plating, the cells attained 70%–
80% confluence and were passaged. The average passage
time was 3–5 days, and the cells could be cultured up to
P11 at most (Figure 2).
Cryogenic preservation and resuscitation
Upon reaching P11, most cells displayed features repre-
sentative of senescence such as blebbing and karyopy-
knosis. After resuscitation, the cells began to adhere at
24 h and grew rapidly thereafter. There was no signifi-
cant difference in growth and morphology between cells
before and after cryopreservation (Table 2).
Growth kinetics
Growth and proliferation of EPCs were similar at P1, P5
and P9 according to the growth curves (data not shown).
After a latency phase of 1–3 days, cell growth entered
the logarithmic phase, and reached the plateau phase at
approximately day 7. The population doubling time
(PDT) was determined to be 32.5h, 31.9 h and 35.6h for
P1, P5 and P9, respectively.
Dil-ac-LDL and FITC-UEA- detection
EPCs have the ability to uptake Dil acetylated low dens-
ity lipoprotein (Dil-ac-LDL) and FITC-Oxytropis lectin 1
(FITC-UEA-I). Thus the capacity of chicken EPCs to
uptake these two proteins was tested. Both Dil-ac-LDL
and FITC-UEA-1 were detected in the chicken EPCs.
Dil-ac-LDL (red) was predominantly localized in the
cytolymph while FITC-UEA-1 (green) was mostly in theroplates after 0 hours; B. ’blood island’ structures of the EPCs; C.
PCs before passage; F. P3 EPCs before passage; G. P5 EPCs before
Table 2 The viability of EPCs before and after
cryopreservation was determined using the Trypan blue
exclusion test
Category Endothelial Progenitor Cells(%)
Before Frozen 92.2 ± 0.21
After Reviving 81.1 ± 0.43
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detected when both Dil-ac-LDL and FITC-UEA-1 were
absorbed [15],[16] (Figure 3).
Immunofluorescence
CD133, CD34 and VEGFR-2 are specific markers of
EPCs. Thus, to further confirm the identity of chicken
EPCs, we examined the expression of these markers in
P1, P5 and P9 cells by immunofluorescent staining. We
found that the cells expressed the three markers at each
passage number (Figure 4).
The weibel-palade body detection
Weible-Palade bodies are endothelial specific organelles.
Indeed, under the transmission electron microscope,
Weible-Palade bodies were observed in chicken EPCs. InFigure 3 Chicken EPC uptake of DiI-ac-LDL and FITC-UEA-1. EPCs were
by immunofluorescent microscopy. DiL-acLDL (red); FITC-UEA-1 (green), diff
C: FITC-UAE-1+; D: Dil-acLDL & FITC-UAE1+ C; E: Merged; F, H ,G ,I: View fieaddition, many organelles such as phagocytic vesicles,
mitochondria, and endoplasmic reticulum, were also
observed, indicative of active cell metabolism in the
chicken EPCs (Figure 5).
Endothelial differentiation of the EPCs
The capacity for chicken EPCS to differentiate into endo-
thelial cells was tested by induction with VEGF and subse-
quent morphological and phenotypic analysis. Ten days
after induction of cells with VEGF, the cell morphology
changed from spindle- to round- or irregularly-shaped,
until the cells were very closely located to each other and
developed a cobblestone pattern (Figure 2D). To confirm
that differentiation had occurred, the expression of endo-
thelial markers was examined in the VEGF-induced EPCs
by immunofluorescent staining. Induced cells were posi-
tive for the endothelial markers CD34 and VEGFR-2, but
negative for the progenitor cell marker CD133 (Figure 6).
In addition, CD34 and VEGFR-2 mRNA expression before
and after differentiation of EPCs was monitored by RT-
PCR. Analysis of the data using the software Gelpro32
suggested that induction of EPC differentiation correlated
with upregulation of CD34 and VEGFR-2 gene expression
(Figure 7). Together, these data indicate that the chickenincubated with DiL-ac-LDL and FITC-UEA-1, uptake was then assessed
erentiated EPCs (yellow). (bar = 50μm) A: Phase contrast; B: Dil-acLDL+;
lds that zoom in from figure E.
Figure 4 Expression of EPC surface markers in chicken EPCs. Expression of the EPC-specific markers CD133, CD34 and VEGFR-2 were
examined by immunofluorescent labeling in chicken EPCs. CD133 marks both hematopoietic stem cells and EPCs. Its expression is gradually lost
upon differentiation of EPCs into mature cells. A, D, and G. Phase contrast; B. VEGFR-2+; E. CD133+; H. CD34; C, F, and I. Merged.
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in vitro (Figure 7).
Smooth muscle cell differentiation of the EPCs
The ability of chicken EPCs to differentiate into smooth
muscle cells was also tested. The cell morphology was
changed at seven days after induction with PDGF-BB. TheFigure 5 Weibel-Palade bodies of chicken EPCs under
transmission electron microscope. Weible-Palade bodies, organelles
characteristic of endothelial cell lines are indicated. Phagocytic vesicles,
mitochondria, and endoplasmic reticulum are also indicated. Their
presence suggests active cellular metabolism. (bar = 600μm).cells became longer and formed structures typical of
muscle cells. The expression of α-MSA, a specific marker
for smooth muscle cells, and CD133, a marker for endothe-
lial progenitor cells, was detected by immunofluorescence
and RT-PCR. In both assays, PDGF-BB-induced EPCs were
α-MSA positive and CD133 negative (Figure 8), suggesting
that EPCs can be induced with PDGF-BB to differentiate
into smooth muscle cells in vitro.
Discussion
EPCs (also known as CD34+CD133+VEGFR-2+ cell)
were first isolated from peripheral blood by Asahara et
al in 1997 [1], and have the ability to differentiate into
mature endothelial cells and take part in angiogenesis.
EPCs and hematopoietic stem cells originate from
angioblasts and normally form blood islands [17]. EPCs
are usually isolated from umbilical cord blood or per-
ipheral blood, however, approximately 3% of EPCs are
found in bone marrow mononuclear cells [18]. In this
study, we characterized EPCs isolated from chicken
bone marrow.
The isolation methods of EPCs in vitro include flow
cytometry, MASC (Magnetic Activated Cell Sorting) and
density centrifugation. Density centrifugation is usually
used for mononuclear cells such as hematopoietic cells
Figure 6 Identification of endothelial cells by immunofluorescent labeling. EPC morphology changed from spindle to rounded or irregular
in shape, until the cells were very closely located and became cobblestone-shaped. The EPCs were negative for the stem cell marker CD133. A, D
and G. Phase contrast; B, E and H. Merge; C. CD34+; F. KDR +; H. CD133-.
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characterized by high density, low osmotic pressure and
non-toxicity. For the culture conditions, Medium B used
in conjunction with fibronectin as a matrix, has previ-
ously been reported to provide the best proliferative
conditions for mammalian cell types in vitro [1] [18].
However, it was not the best for our chicken-derived cell
cultures. In comparison to other mammal-derived EPCs,
the proliferation of chicken EPCs was slower and not
easy to rapidly passage. Because DMEM/F12 (MediumFigure 7 Detection of EPC markers by RT-PCR. The expression of CD34
different (P< 0.05) before and after induction of differentiation as detected
2. GAPDH; 3. VEGFR-2.A) has greater nutritive constituents than M199
(Medium B), it was used to maintain chicken EPCs in
culture. We speculate that the different media prefer-
ence is related to species-specific characteristics.
The identification criteria of EPCs include cell morph-
ology, specific antigen markers and self-renewal ability.
The morphology of EPCs changes from short spindle-
shaped cells, cell colonies and linear arrays to a typical
cobblestone-like shape during differentiation to mature
endothelial cells [19]. CD34+CD133+VEGFR-2+ cells areand VEGFR-2, endothelial cell specific markers were significantly
by RT-PCR. Data were analyzed using the Gelpro32 software. 1. CD34;
Figure 8 Smooth muscle cells were identified by immunofluorescence and RT-PCR. EPC morphology changed after induction with
PDGF-BB at day 7, whereby the cells became longer in shape and formed structures typical of muscle cells. The induced cells were negative for the
stem cell marker CD133 and positive for the smooth muscle cells marker α-MSA, as detected by immunofluorescence and RT-PCR. A and D. Phase
contrast; B. α-MSA+; E. CD133- C. and F. Merge; G. smooth muscle cells marker α-MSA detection via RT-PCR, 1: Marker. 2: GAPDH. 3: α-MSA.
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CD133 (also known as AC133) is a marker for
hematopoietic stem cells and EPCs, and is gradually lost
as EPCs differentiate into mature endothelial cells. CD34
is also an antigen marker for hematopoietic and endothe-
lial cell lines. VEGFR-2 (also known as FLK-1 and KDR) is
a specific marker for endothelial cells. vWF also functions
as a specific marker for endothelial cell lineage. It is pro-
duced by endothelial cells and located in the cytoplasm of
Weibel-Palade bodies. Thus vWF and Weibel-Palade bod-
ies serve as specific markers for endothelial identification
[22] [23]. Moreover, the specific ability of endothelial cells
to uptake both Dil-ac-LDL and FITC-UEA-1 can be used
to identify endothelial cell types. In this experiment, EPCs
were identified through detection of the markers CD34,
CD133 and VEGFR-2 using immunofluorescence. Uptake
of fluorescently labeled Dil-ac-LDL and FITC-UEA-1also
revealed that the EPCs were double positive for these indi-
cators. Moreover, Weibel-Palade bodies were observed by
transmission electron microscopy. Thus the chicken EPCs
retained characteristics typical of EPCs in vitro.
EPCs are responsible for the construction of the blood
vessel lumen, and are able to differentiate into matureendothelial cells and smooth muscle cells. There are
many factors influencing the differentiation of EPCs into
mature endothelial cells, among which the central factor
is VEGF. Apart from inducing the differentiation of
EPCs, VEGF also induces the differentiation of other
stem/progenitor cells into mature endothelial cells [19].
The underlying mechanisms are far from clear, except
that the VEGF receptor (R)-2 is located on endothelial
cell membranes, and that activation of protein kinase B
by VEGF initiates various intracellular signaling path-
ways, which promote the growth and differentiation of
cells through the activation of inositol triphosphate [24].
In our study, the concentration of VEGF used to induce
differentiation was five-fold higher than that contained
within the growth medium, thus greatly promoting dif-
ferentiation of EPCS into mature endothelial cells.
Through RT-PCR, CD34 and VEGFR-2 mRNA expres-
sion were found to be significantly different (P< 0.05)
before and after VEGF-induced differentiation of EPCs
into mature endothelial cells. Thus, cultured chicken
EPCs can develop into mature endothelial cells in re-
sponse to VEGF as identified by morphological and
phenotypic characteristics.
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cells. Smooth muscle cells are the main functional cells of
the vascular mesosphere and are involved in the synthesis
of the vascular matrix and vasomotor function. Platelet-
derived growth factor-BB (PDGF-BB) was used to induce
EPC differentiation into smooth muscle cells. Seven days
post-induction, cells with myoid morphology were
observed. In accordance with the morphology, immunola-
belling for the stem cell marker CD133 was negative in the
inducted cells, while expression of the smooth muscle cell
specific marker α-MSA was positive as determined using
immunofluorescence and RT-PCR. Together, these data in-
dicate that chicken EPCs can be differentiated into both
mature endothelial cells and smooth muscle cells by stimu-
lation with VEGF and PDGF-BB, respectively, in vitro.Conclusion
In conclusion, this study establishes an optimized
method for the isolation and culture of chicken EPCs as
suggested by characterization of cell morphology, surface
markers and biological features. We also demonstrate
that chicken EPCs can be induced to differentiate into
endothelial and smooth muscle cells, which supports the
notion that the chicken EPCs retained multipotency.
This study not only provides a technological platform
for the establishment of a chicken EPC bank, but also
proposes a new method to preserve the valuable genetic
resources of chicken and other poultry.
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